HillSignal

TICKER INTELLIGENCE

Gilead Sciences, Inc. ($GILD)

$133.21 1.6% (7d)

NYSE/NASDAQ: GILD

Washington Intelligence

3

Active Bills

0

Gov't Contracts

50

Congressional Trades

Gilead Sciences is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 3 active Congressional signals mentioning Gilead Sciences, including 3 bills. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.

Congressional Trades in $GILD

50 filings
Alan Armstrong
BUY $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock

⚠️ PRESIDENTIAL ACTION: Presidential Memorandum signed 7/30/2026: "Presidential Determination Pursuant to Section 101 of the Defense Production Act of 1950, as Amended". This DPA action will boost investment and production in domestic critical mineral recycling and processing, likely increasing stock valuations for pure-play recovery companies and defense contractors reliant on secure rare-earth magnet supplies, while potentially raising costs for import-dependent manufacturers.

2026-07-21
3 flags
Jared Moskowitz
BUY $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock P (GILD)
BUY $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock P (GILD)

System: No overlapping signals found

2026-06-22
1 flag
Josh Gottheimer
BUY $1,001 - $15,000 — Gilead Sciences Inc

System: No overlapping signals found

2026-02-27
1 flag
Josh GottheimerD-NJ
BUY $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock

Josh Gottheimer sold $1,001 - $15,000 in UBER on 2026-01-30 — 34 days before S4010, 'A bill to clarify the classification of service provider payees as employees or independent contractors in Federal law,' was introduced. This bill could increase operational costs for gig economy companies.

2026-02-26
5 flags
Valerie HoyleD-OR
SELL $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock

System: No suspicious timing patterns detected

2025-10-10
1 flag
Valerie HoyleD-OR
BUY $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock

System: No suspicious timing patterns detected

2025-09-12
1 flag
Marjorie Taylor Greene
BUY $1,001 - $15,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2025-06-19
1 flag
Marjorie Taylor GreeneR-GA
BUY $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock

Rep. Marjorie Taylor Greene bought $1,001 - $15,000 in GILD on June 6, 2025 — 90 days before HR5127 ("PrEP and PEP are Prevention Act") was introduced, a bill that could increase demand for HIV prevention drugs.

2025-06-18
3 flags
Josh Gottheimer
SELL $1,001 - $15,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2025-06-12
1 flag
Josh GottheimerD-NJ
SELL $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock

Rep. Gottheimer bought $1,001 - $15,000 in MSFT on 2025-05-21 — 1 day before the "Access Technology Affordability Act of 2025" (S1918) was introduced, which could offer tax credits for technology purchases.

2025-06-11
4 flags
John Boozman
SELL $1,001 - $15,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2025-05-14
1 flag
Marjorie Taylor Greene
BUY $1,001 - $15,000 — Gilead Sciences Inc (1)

System: No suspicious timing patterns detected

2025-05-07
1 flag
Marjorie Taylor GreeneR-GA
BUY $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock (GILD)
BUY $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock (GILD)

System: No suspicious timing patterns detected

2025-05-06
1 flag
Jefferson Shreve
BUY $15,001 - $50,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2025-04-14
1 flag
Carol Devine MillerR-WV
BUY $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock (GILD) [ST]

Rep. Carol Devine Miller sold $1,001 - $15,000 in UPS on March 10, 2025 — 30 days before the "Protecting Employees and Retirees in Business Bankruptcies Act of 2025" (S. 1381) was introduced, a bill with potential bearish implications for corporations.

2025-04-11
5 flags
Josh Gottheimer
BUY $1,001 - $15,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2025-04-11
1 flag
Jefferson ShreveR-IN
BUY $15,001 - $50,000 — Gilead Sciences, Inc. - Common Stock (GILD)

System: No suspicious timing patterns detected

2025-04-11
1 flag
Josh GottheimerD-NJ
BUY $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock (GILD)

Rep. Gottheimer sold $1,001 - $15,000 in DHI on 2025-03-19 — 8 days before the 'Revitalizing Downtowns and Main Streets Act' (HR2410) was introduced, a bill proposing an investment tax credit for converting non-residential buildings.

2025-04-10
5 flags
Marjorie Taylor Greene
BUY $1,001 - $15,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2024-12-30
1 flag
Marjorie Taylor Mrs GreeneR-GA
BUY $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock (GILD)

Rep. Greene bought $1K-$15K in NSC on Dec 24, 2024 — 23 days before HR516 was introduced, a bill that would increase the railroad track maintenance tax credit by 74%, directly benefiting Norfolk Southern.

2024-12-27
5 flags
Rohit KhannaD-CA
BUY $1,001 - $15,000 — GILEAD SCIENCES CMN

System: No suspicious timing patterns detected

2024-12-05
1 flag
Thomas H Tuberville
BUY $1,001 - $15,000 — Gilead Sciences Inc Option Type: Put Strike price: $70.00 Expires: 11/15/2024
BUY $1,001 - $15,000 — Gilead Sciences Inc Option Type: Put Strike price: $70.00 Expires: 11/15/2024
BUY $1,001 - $15,000 — Gilead Sciences Inc Option Type: Put Strike price: $70.00 Expires: 11/15/2024
SELL $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock
2024-06-14
Tommy Tuberville
BUY $1,001 - $15,000 — Gilead Sciences Inc
SELL $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock

System: No suspicious timing patterns detected

2024-06-14
1 flag
Tommy Tuberville
BUY $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock
SELL $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock

System: No suspicious timing patterns detected

2024-05-15
1 flag
Ro Khanna
BUY $1,001 - $15,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2024-04-05
1 flag
Rohit KhannaD-CA
BUY $1,001- $15,000 — GILEAD SCIENCES CMN

System: No suspicious timing patterns detected

2024-04-05
1 flag
Ro Khanna
SELL $1,001 - $15,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2024-03-06
1 flag
Rohit KhannaD-CA
SELL $1,001 - $15,000 — GILEAD SCIENCES CMN

System: No suspicious timing patterns detected

2024-01-04
1 flag
Ro Khanna
BUY $1,001 - $15,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2023-12-06
1 flag
Rohit KhannaD-CA
BUY $1,001 - $15,000 — GILEAD SCIENCES CMN

System: No suspicious timing patterns detected

2023-12-06
1 flag
Greg StantonD-AZ
SELL $1,001 - $15,000 — Gilead Sciences Inc
BUY $1,001 - $15,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2023-11-09
1 flag
Ro Khanna
SELL $1,001 - $15,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2023-11-08
1 flag
Daniel GoldmanD-NY
SELL $15,001 - $50,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2023-08-13
1 flag
Zoe Lofgren
SELL $1,001 - $15,000 — Gilead Sciences Inc

System: No valid trades to analyze

2023-06-06
1 flag
Daniel GoldmanD-NY
BUY $15,001 - $50,000 — Gilead Sciences, Inc.

System: No valid trades to analyze

2023-04-17
1 flag
Zoe Lofgren
BUY $1,001 - $15,000 — Gilead Sciences, Inc.

System: No suspicious timing patterns detected

2022-10-11
1 flag
Ro Khanna
BUY $1,001 - $15,000 — Gilead Sciences Inc
BUY $1,001 - $15,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2022-10-07
1 flag
Ro Khanna
SELL $1,001 - $15,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2022-09-08
1 flag
Carol Devine Miller
SELL $15,001 - $50,000 — Gilead Sciences, Inc.

System: No suspicious timing patterns detected

2022-09-02
1 flag
Ro Khanna
BUY $1,001 - $15,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2022-06-10
1 flag
Ro Khanna
BUY $1,001 - $15,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2022-05-06
1 flag
Ro Khanna
SELL $1,001 - $15,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2022-03-08
1 flag
Tommy Tuberville
SELL $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock

System: No suspicious timing patterns detected

2022-02-14
1 flag
Ro Khanna
SELL $1,001 - $15,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2022-02-08
1 flag
Jerry Moran
SELL $1,001 - $15,000 — Gilead Sciences, Inc. - Common Stock

System: No suspicious timing patterns detected

2022-01-21
1 flag
Roger W. Marshall
SELL $1,001 - $15,000 — Gilead Sciences Inc

System: No suspicious timing patterns detected

2021-09-28
1 flag
Sara Jacobs
SELL $15,001 - $50,000 — Gilead Sciences, Inc

System: No suspicious timing patterns detected

2021-05-28
1 flag
Ro Khanna
BUY $1,001 - $15,000 — Gilead Sciences Inc (Ritu 1985 Trust)

System: No suspicious timing patterns detected

2021-03-12
1 flag
Marjorie Taylor Greene
BUY $1,001 - $15,000 — Gilead Sciences, Inc.

System: No suspicious timing patterns detected

2021-02-19
1 flag
Gilbert Cisneros
SELL $1,001 - $15,000 — Gilead Sciences, Inc. (U.S. Trust Holdings)

System: No suspicious timing patterns detected

2021-01-11
1 flag

📋 On the Inside — Form 4 Activity in $GILD

SELLChairman & CEO5d ago

O'Day Daniel Patrick sold $2.0M of $GILD

15,000 shares @ $130.31

Form 4 →

Related Sectors

Congressional Legislation Affecting Gilead Sciences, Inc. ($GILD)

The PrEP and PEP are Prevention Act (HR5127) mandates zero-cost coverage of HIV prevention drugs and associated lab monitoring across all US insurance programs. This early-stage bipartisan bill creates direct volume upside for Gilead ($GILD) on branded PrEP, Viatris ($VTRS) on generic PrEP, and Labcorp ($LH) on mandatory diagnostic services. Merck ($MRK) is excluded from the causal chain because its islatravir candidate is not FDA-approved and the bill only covers approved drugs.

Insurers must cover Gilead's branded PrEP drugs (Truvada, Descovy) and associated lab monitoring without cost-sharing or prior authorization, removing price sensitivity and administrative barriers for patients, which is expected to increase prescription volumes significantly.

HR5127

HR1492 retroactively extends the Medicare price negotiation safe harbor for small-molecule drugs from 7 to 11 years, matching biologics. This shields billions in revenue for major pharma companies, particularly pure-play small-molecule firms like Vertex and large players with top-selling Part D drugs like Pfizer, Bristol-Myers Squibb, and Gilead. The bill is early-stage with 67 cosponsors and a Republican sponsor, giving it moderate momentum.

Gilead's antiviral and oncology small-molecule drugs (e.g., Biktarvy, Descovy, Trodelvy) are shielded from negotiation for an additional 4 years.

HR1492

HR7385 is an early-stage bill authorizing up to $10M per grant for PrEP programs, with no specified total funding or direct corporate beneficiaries. It has been referred to committee with 14 cosponsors, all Democrats. At this procedural stage, the bill has no measurable market impact.

HR7385

Understanding These Signals

Get Full Access to Gilead Sciences, Inc. ($GILD) Signals

Daily AI-analyzed alerts for Congressional activity affecting your portfolio.

Get Started →